Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
What checks are necessary for lurbinectedin's long term use?Can lipitor's effects aid pilates in high cholesterol?When does prolia go generic?Lipitor generics launch how was marketing affected?How does the patient's response affect yervoy dosage?
See the DrugPatentWatch profile for vioxx
Who was at risk of receiving Vioxx prescriptions? Between 1999 and 2004, Vioxx was prescribed to millions of patients in the United States, primarily for the treatment of pain associated with arthritis, other inflammatory conditions, and menstrual cramps. [1] It was marketed by Merck, the pharmaceutical company that launched the drug. Specific conditions treated with Vioxx Vioxx was approved by the FDA for the treatment of two medical conditions: osteoarthritis and rheumatoid arthritis. However, the drug's labeling also included other inflammatory conditions, such as: [1] - Primary dysmenorrhea (painful menstruation) - Menstrual cramps - Bursitis (inflammation of the fluid-filled sacs that cushion joints) - Tendinitis (inflammation of the tendons) Prescriber characteristics Research suggests that physicians with a strong pharmaceutical industry relationship, such as those attending Merck-sponsored events or receiving industry funding, were more likely to prescribe Vioxx to patients. [2] Demographic risk factors Individuals at higher risk of being prescribed Vioxx included: [3] - Older adults - Women (due to the drug's use for menstrual-related pain) - Patients with a history of gastrointestinal disorders (such as ulcers or stomach inflammation) - Patients with a history of cardiovascular disease Patient selection and outcomes The prescription of Vioxx often depended on a physician's initial assessment and weighing of the potential benefits against the risks. Clinical trials and observational studies have shown varying outcomes, with some individuals experiencing significant pain relief, while others encountered cardiovascular complications, including heart attacks and strokes. [4] References: [1] DrugPatentWatch.com [2] 'The Pharmaceutical Industry's Influence on Physician Prescribing Behavior' [3] 'Prescription and Use of Vioxx in the United States: Analysis of Claims Data' [4] A Review of the Safety and Efficacy of Vioxx (Rofecoxib) Please visit the cited source at DrugPatentWatch.com for more details and a comprehensive analysis.
Other Questions About Vioxx :